Description
CJC-1295 NO DAC/Modified GRF 1-29
Research Applications: CJC-1295 NO DAC (Modified GRF 1-29) is a growth hormone-releasing factor analog extensively studied in laboratory research for its role in neuroendocrine signaling pathways. Researchers investigate this peptide in controlled academic environments to explore its interactions with specific pituitary and hypothalamic mechanisms. The compound has been the subject of numerous in vitro and animal model studies examining its effects on growth hormone secretion in research settings.
Mechanism: In research applications, CJC-1295 NO DAC is studied for its potential interactions with growth hormone-releasing factor receptors involved in neuroendocrine regulation. Laboratory investigations suggest it may modulate specific signaling pathways related to hormone secretion mechanisms. Researchers continue to explore its detailed effects through controlled experimental approaches.
Technical Specifications:
- Purity: 99%
- Molecular Weight: 1468.68
- Form: Lyophilized Powder
- Storage: 2-8°C, protect from light
For Research Use Only This product is intended for laboratory and research purposes exclusively. Not intended for human consumption.